Patents Assigned to NanoDesign, Inc.
  • Non-steroidal estrogen receptor ligands
    Patent number: 6599921
    Abstract: Novel non-steroidal estrogen receptor ligands and methods of synthesis are disclosed. The novel molecules are intended for use in therapeutic preparations for the treatment of estrogen receptor related disease states. The compounds specified are tetra-cyclic derivatives and have been shown to be antiproliferative against human estrogen-dependent cancer cells and to have good binding affinity for the estrogen receptor.
    Type: Grant
    Filed: August 21, 2001
    Date of Patent: July 29, 2003
    Assignee: NanoDesign, Inc.
    Inventors: Jonathan Martin Schmidt, Julie Mercure, Jeffry Lawrence Lowell, Stefan Kwiatkowski, Krzysztof Pupek, Shuguang Zhu, John Whelan, Natalie Lazarowych